NeoGenomics, Inc. Non Peo Neo Avg Total Comp Amt
NeoGenomics, Inc. (NEO) reported Non Peo Neo Avg Total Comp Amt of $3.81 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-06.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-06
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $3.81M DEF 14A · filed 2026-04-06 |
| 2024-12-31 | $2.81M DEF 14A · filed 2026-04-06 |
| 2023-12-31 | $3.41M DEF 14A · filed 2026-04-06 |
| 2022-12-31 | $2.69M DEF 14A · filed 2026-04-06 |
| 2021-12-31 | $4.04M DEF 14A · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |